- Xenoextracellular matrix-rosiglitazone complex-mediated immune evasion promotes xenogenic bioengineered root regeneration by altering M1/M2 macrophage polarization
Tingting Lan et al, 2021, Biomaterials CrossRef - The Brown Algae Ishige sinicola Extract Ameliorates Ovariectomy-Induced Bone Loss in Rats and Suppresses Osteoclastogenesis through Downregulation of NFATc1/c-Fos
Mihyang Kim et al, 2022, Nutrients CrossRef - A novel drug combination of Tofacitinib and Iguratimod alleviates rheumatoid arthritis and secondary osteoporosis
Jie Chen et al, 2023, International Immunopharmacology CrossRef - Iguratimod as a New Drug for Rheumatoid Arthritis: Current Landscape
Sisi Xie et al, 2020, Frontiers in Pharmacology CrossRef - Influence of Iguratimod on Bone Metabolism in Patients with Rheumatoid Arthritis: A Meta-analysis
Li Deng et al, 2022, International Journal of Clinical Practice CrossRef - The add-on effectiveness and safety of iguratimod in patients with rheumatoid arthritis who showed an inadequate response to tocilizumab
Kosuke Ebina et al, 2019, Modern Rheumatology CrossRef - Anti-fibrotic effect of iguratimod on pulmonary fibrosis by inhibiting the fibroblast–to-myofibroblast transition
Haobo Lin et al, 2020, Advances in Medical Sciences CrossRef - Baohuoside I Inhibits Osteoclastogenesis and Protects Against Ovariectomy-Induced Bone Loss
Min Ma et al, 2022, Frontiers in Pharmacology CrossRef - Iguratimod Restrains Circulating Follicular Helper T Cell Function by Inhibiting Glucose Metabolism via Hif1α-HK2 Axis in Rheumatoid Arthritis
Ziran Bai et al, 2022, Frontiers in Immunology CrossRef - Effectiveness and Safety of Iguratimod in Treating Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis
Jincheng Pu et al, 2021, Frontiers in Pharmacology CrossRef - Cardiovascular Involvement in Sjögren’s Syndrome
Fabiola Atzeni et al, 2022, Frontiers in Immunology CrossRef - Role of PPARs in Progression of Anxiety: Literature Analysis and Signaling Pathways Reconstruction
Olga I. Rudko et al, 2020, PPAR Research CrossRef - Iguratimod inhibits osteoclastogenesis by modulating the RANKL and TNF-α signaling pathways
Chang-hong Li et al, 2021, International Immunopharmacology CrossRef - Efficacy and safety of Iguratimod in the treatment of Ankylosing Spondylitis: A systematic review and meta-analysis of randomized controlled trials
Zhiyong Long et al, 2023, Frontiers in Immunology CrossRef - Efficacy and safety of iguratimod combined with methotrexate vs. methotrexate alone in rheumatoid arthritis
L.-J. Chen et al, 2021, Zeitschrift für Rheumatologie CrossRef - Effects of iguratimod on glucocorticoid-induced disorder of bone metabolism in vitro
Akira Miyama et al, 2021, Journal of Bone and Mineral Metabolism CrossRef - The PPAR-γ antagonist T007 inhibits RANKL-induced osteoclastogenesis and counteracts OVX-induced bone loss in mice
Xiang Li et al, 2019, Cell Communication and Signaling CrossRef - Efficacy and safety of iguratimod combined with celecoxib in active axial spondyloarthritis: a randomized, double-blind, placebo-controlled study
X Chen et al, 2024, Scandinavian Journal of Rheumatology CrossRef - Cinnamic acid decreases periodontal inflammation and alveolar bone loss in experimental periodontitis
Ozkan Karatas et al, 2020, Journal of Periodontal Research CrossRef - Iguratimod: a valuable remedy from the Asia Pacific region for ameliorating autoimmune diseases and protecting bone physiology
Jie Li et al, 2019, Bone Research CrossRef - Molecular mechanisms and clinical application of Iguratimod: A review
Huihui Jiang et al, 2020, Biomedicine & Pharmacotherapy CrossRef - Iguratimod suppresses sclerostin and receptor activator of NF-κB ligand production via the extracellular signal–regulated kinase/early growth response protein 1/tumor necrosis factor alpha pathway in osteocytes and ameliorates disuse osteoporosis in mice
Taihei Miura et al, 2024, Bone CrossRef